Search Results 61-70 of 14846 for anti-TNF drugs

1. Publications - Sunanda V. Kane, M.D. - Mayo Clinic

   Safety of anti-TNF agents in pregnancy. J Allergy Clin Immunol. 2021 Sep; 148 (3):661-667. View PubMed; Katz S, Kane SV. Myths and Misconceptions in the ...

2. Mayo Clinic Q and A: With psoriatic arthritis, the sooner therapy is started, the better

   NSAIDs — If your symptoms are mild, nonsteroidal anti ... Disease-modifying antirheumatic drugs (DMARDs) — These drugs ... TNF-alpha inhibitors block this substance ...

3. Microscopic colitis - Diagnosis and treatment - Mayo Clinic

   Biologic medicines, such as infliximab (Remicade), adalimumab (Humira) or vedolizumab (Entyvio). These can reduce swelling and irritation in the colon. Surgery.

4. COVID-19 drugs: Are there any that work? - Mayo Clinic

   The U.S. Food and Drug Administration (FDA) authorized this treatment to prevent COVID-19 in some people with weakened immune systems. Medicines to treat COVID- ...

5. Mayo Clinic researchers to present study findings at American College of Gastroenterologists Annual Scientific Meeting

   "When we examined the risk for preeclampsia in those on anti-TNF therapy ... "We theorize that exposure to anti-TNF agents is a marker of more severe ...

6. A Study to Evaluate both the Efficacy and Safety Profile of CP-690,550 in Patients with Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

   ... anti-TNF-alpha therapy. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...

7. A Study of Etanercept and Methotrexate in Combination or as Monotherapy in Psoriatic Arthritis - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic Health ... etanercept for the treatment of patients with psoriatic arthritis (PsA).

8. A Study of the Efficacy and Safety of Etrolizumab in Ulcerative Colitis Participants Who Are Refractory to or Intolerant of Tumor Necrosis Factor (TNF) Inhibitors - Mayo Clinic

   Intolerance, loss response or failure to respond to treatment with at least one TNF-inhibitor within the previous 5 years; Washout of anti-TNF therapy for at ...

9. A Study of RoActemra/Actemra (Tocilizumab) in Comparison to Etanercept in Patients With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors - Mayo Clinic

   Previous treatment with tocilizumab or etanercept. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for the ...

10. Breast cancer chemoprevention: Drugs that reduce risk - Mayo Clinic

    Preventive medications can reduce breast cancer risk. Learn about how these drugs work, who should consider taking them, plus their side effects and health ...